In a significant crackdown on international drug trafficking, Qingzhou Wang and Yiyi Chen, two executives from a Chinese chemical company known for manufacturing fentanyl precursors, have been handed substantial prison sentences in the United States. According to an official press release from the U.S. Attorney’s Office for the Southern District of New York, Wang, the company's top executive, will serve 25 years, while Chen, the marketing manager, received a 15-year sentence.
Following a two-week jury trial that ended on February 3, U.S. District Judge Paul G. Gardephe convicted two Chinese nationals. “American families are burying loved ones because of fentanyl and individuals like Qingzhou Wang and Yiyi Chen who unlawfully market and supply the ingredients to make it,” U.S. Attorney Jay Clayton said in the press release.
The convicted executives were part of Amarvel Biotech, based in Wuhan, China, which shipped over 200 kilograms of fentanyl-related precursors to the United States. They conducted business by disguising these deadly chemicals as mundane goods, and earning through cryptocurrency transaction.
Details of their operation unravelled during undercover DEA stings between 2022 and 2023, where DEA confidential sources posed as traffickers to entice Amarvel Biotech into selling immense quantities of fentanyl precursors, despite explicitly stating its intended use for fentanyl production in New York and the resultant American casualties. The undercover operations led to the seizure of shipments and the interception of encrypted communications outlining the company's distribution strategy, which targeted Mexican cartels and took pains to evade U.S. law enforcement interdiction.
In addition to their prison terms, Wang and Chen are to undergo three years of supervised release post-incarceration. Wang was ordered to forfeit just over $67,000 while Chen must forego a dozen seized internet domain names. The press release credits the combined efforts of numerous DEA offices and international law enforcement agencies for the successful operation. Assistant U.S. Attorneys Alexander Li and Kevin Sullivan were noted as leading the prosecution, with support from Paralegal Specialist Sabrina Jim Munoz.
